The impact of CBP expression in estrogen receptor-positive breast cancer
Wafaa S. Ramadan(University of Sharjah), Raafat El‐Awady(American Association of Colleges of Pharmacy)
Cited by 37
Related Papers
Effect of safranal on the response of cancer cells to topoisomerase I inhibitors: Does sequence matter?
|Frontiers in Pharmacology|2022|24
Design, synthesis and mechanistic anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives
|iScience|2023|8
Discovery of Novel Class of Histone Deacetylase Inhibitors as Anticancer Agents
|Research Square|2021|0